Norma Alonzo Palma

1.9k citations

28 papers · 746 indexed · h-index 11

Oncology top 10%
- Pancreatic and Hepatic Oncology Research 3
Cancer Research top 10%
- Cancer Genomics and Diagnostics 12
Urology top 5%
Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Bladder and Urothelial Cancer Treatments 3
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations 7
- Advanced Breast Cancer Therapies 2
- Renal cell carcinoma treatment 2
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 2

Co-authors: Vincent A. Miller Siraj M. Ali Jeffrey S. RossKai WangPhilip J. Stephens Doron Lipson Roman Yelensky Juliann Chmielecki
Cited by: Oncology Cancer Research Urology
Journals: Journal of Clinical Oncology (11 papers)Cancer (1 paper)Cancer Research (1 paper)
Partner nations: United States Sweden Israel

In The Last Decade

Norma Alonzo Palma

26 papers receiving 738 citations

Peers

Countries citing papers authored by Norma Alonzo Palma

Since Specialization

Citations

This map shows the geographic impact of Norma Alonzo Palma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Alonzo Palma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Alonzo Palma more than expected).

Fields of papers citing papers by Norma Alonzo Palma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Alonzo Palma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Alonzo Palma. The network helps show where Norma Alonzo Palma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Norma Alonzo Palma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norma Alonzo Palma Line = papers co-authored together Norma Alonzo Palma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma Current Oncology ·Patricio M. Polanco,Tamas A. Gonda,Erkut Borazanci,Evan S. Glazer,José G. Treviño,George R. DeMuth,Lisa A. Ford,Thomas C. King,Norma Alonzo Palma,Randall E. Brand	2025	0
2	A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals Cancers ·Norma Alonzo Palma,Aimee L. Lucas,Bryson W. Katona,Alcibiade Athanasiou,Natasha Kureshi,Lisa Ford,Thomas Keller,Stephen G. Weber,Ralph Schiess,Thomas C. King,Diane M. Simeone,Randall E. Brand	2025	3
3	UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer Gynecologic Oncology ·Debra J. Richardson,Gopa Iyer,Anita Schmid,Norma Alonzo Palma,Willis H. Navarro,Jordi Rodón	2024	1
4	nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program. Journal of Clinical Oncology ·Mark A. Dickson,Vinod Ravi,Richard F. Riedel,Kristen N. Ganjoo,Brian Andrew Van Tine,Rashmi Chugh,Lee D. Cranmer,Erlinda M. Gordon,James Lin Chen,Martina Murphy,Anita N. Schmid,Neil Desai,Norma Alonzo Palma,David J. Kwiatkowski,Andrew J. Wagner	2022	3
5	Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies JCO Precision Oncology ·Allison R. Greenplate,Kai Wang,Rati Tripathi,Norma Alonzo Palma,Siraj M. Ali,Phil Stephens,Vincent A. Miller,Yu Shyr,Yan Guo,Nishitha Reddy,Lina Kozhaya,Derya Unutmaz,Xueyan Chen,Jonathan M. Irish,Utpal P. Davé	2018	20
6	Personalized Treatment for a Patient With aBRAFV600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma Journal of the National Comprehensive Cancer Network ·Silviya K. Meletath,Dean C. Pavlick,Timothy J. Brennan,Roy Hamilton,Juliann Chmielecki,Julia A. Elvin,Norma Alonzo Palma,Jeffrey S. Ross,Vincent A. Miller,Philip J. Stephens,George J. Snipes,Veena Rajaram,Siraj M. Ali,Isaac Melguizo‐Gavilanes	2016	20
7	Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations Breast Cancer Research and Treatment ·Jeffrey S. Ross,Siraj M. Ali,Kai Wang,Depinder Khaira,Norma Alonzo Palma,Juliann Chmielecki,Gary A. Palmer,Deborah Morosini,Julia A. Elvin,Sandra V. Fernandez,Vincent A. Miller,Philip J. Stephens,Massimo Cristofanilli	2015	61
8	Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling European Urology ·Sumanta K. Pal,Toni K. Choueiri,Kai Wang,Depinder Khaira,José A. Karam,Eliezer M. Van Allen,Norma Alonzo Palma,Mark N. Stein,Adrienne Johnson,Rachel M. Squillace,Julia A. Elvin,Juliann Chmielecki,Roman Yelensky,Evgeny Yakirevich,Doron Lipson,Douglas I. Lin,Vincent A. Miller,Philip J. Stephens,Siraj M. Ali,Jeffrey S. Ross	2015	87
9	Comprehensive genomic profiling (CGP) of cervical squamous cell carcinoma (cSCC) to identifiy targeted therapy options. Journal of Clinical Oncology ·Julia A. Elvin,Mark Bailey,Benedito A. Carneiro,Siraj M. Ali,Jo‐Anne Vergilio,Norma Alonzo Palma,Juliann Chmielecki,Garrett M. Frampton,Doron Lipson,Phil Stephens,Vincent A. Miller,Melissa L. Johnson,Francis J. Giles,Jeffrey S. Ross,Oliver Dorigo	2015	1
10	Association of PIK3CA mutation with response (ExRx) to cetuximab (C) in metastatic (met) triple-negative breast cancer (TNBC). Journal of Clinical Oncology ·Joyce O’Shaughnessy,Corinne Ramos,Phil Stephens,Nicholas N Hoke,Norma Alonzo Palma,Maren K. Levin,Marina Horiates,Christine E. Horak,Kai Wang	2015	2
11	Abstract P4-15-03: Activating mutations in ERBB2/HER2 as found by FoundationOneTM represent potential therapeutic targets in breast cancer Cancer Research ·Gary A. Palmer,Jeffrey S. Ross,Kai Wang,Garrett M. Frampton,Siraj M. Ali,Norma Alonzo Palma,Deborah Morosini,Vincent A. Miller,Roman Yelensky,Doron Lipson,Philip J. Stephens,Juliann Chmielecki	2015	1
12	Comprehensive genomic profiling of anal squamous cell carcinoma to reveal frequency of clinically relevant genomic alterations in the PI3K/mTOR pathway. Journal of Clinical Oncology ·Eric M. Sanford,Siraj M. Ali,Julia A. Elvin,Garrett M. Frampton,James Sun,Norma Alonzo Palma,Juliann Chmielecki,Roman Yelensky,Doron Lipson,Vincent A. Miller,Philip J. Stephens,Jeffrey S. Ross	2015	1
13	Oncogenic Alterations in ERBB2/HER2 Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin The Oncologist ·Juliann Chmielecki,Jeffrey S. Ross,Kai Wang,Garrett M. Frampton,Gary A. Palmer,Siraj M. Ali,Norma Alonzo Palma,Deborah Morosini,Vincent A. Miller,Roman Yelensky,Doron Lipson,Philip J. Stephens	2014	75
14	Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary Case Reports in Oncology ·Norma Alonzo Palma,Siraj M. Ali,Jamie O'Connor,Deepa Dutta,Kai Wang,Salil Soman,Gary A. Palmer,Deborah Morosini,Jeffrey S. Ross,Doron Lipson,Phil Stephens,Mayur M. Patel,Vincent A. Miller,Nicholas Koutrelakos	2014	23
15	A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib Case Reports in Oncology ·Jon Chung,Siraj M. Ali,Jenni Davis,Karl Robstad,R. McNally,Laurie M. Gay,Rachel Erlich,Norma Alonzo Palma,Phil Stephens,Vincent A. Miller,Alfonso Cutugno,Jeffrey S. Ross	2014	10
16	Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity Journal of Clinical Oncology ·Elizabeth R. Plimack,Jean Hoffman‐Censits,Rosalia Viterbo,Edouard J. Trabulsi,Eric A. Ross,Richard E. Greenberg,David Y.T. Chen,Costas D. Lallas,Yu-Ning Wong,Jianqing Lin,Alexander Kutikov,Efrat Dotan,Timothy Brennan,Norma Alonzo Palma,Essel Dulaimi,Reza Mehrazin,Stephen A. Boorjian,William Kevin Kelly,Robert G. Uzzo,Gary R. Hudes	2014	192
17	Identifying ALK rearrangements that are not detected by FISH with targeted next-generation sequencing of lung carcinoma. Journal of Clinical Oncology ·Siraj M. Ali,Sai‐Hong Ignatius Ou,Jie He,Nir Peled,Juliann Chmielecki,Mary Pinder,Norma Alonzo Palma,Wallace Akerley,Kai Wang,Julian R. Molina,Jeffrey S. Ross,Roman Yelensky,Garrett M. Frampton,Lyudmila Bazhenova,Gary A. Palmer,Deborah Morosini,Doron Lipson,Phil Stephens,Ravi Salgia,Vincent A. Miller	2014	11
18	319 Genomic profiling of uterine leiomyosarcomas reveal frequent alterations in Akt/mammalian target of rapamycin (mTOR) pathway genes and other actionable genomic abnormalities linked to targeted therapies European Journal of Cancer ·J.A. Elvin,Zachary R. Chalmers,J. Chiemlicki,K.A.I. Wang,Norma Alonzo Palma,Sami Ali,Albert Huho,Christine E. Sheehan,V.A. Miller,P.J. Stephens,Jeffrey S. Ross	2014	2
19	Comprehensive genomic profiling of gallbladder adenocarcinoma and frequent genomic-derived targets of therapy. Journal of Clinical Oncology ·Phil Stephens,Kai Wang,Norma Alonzo Palma,Juliann Chmielecki,Rachna T. Shroff,Chaitanya Churi,Garrett M. Frampton,Siraj M. Ali,Milind Javle,Jeffrey S. Ross	2014	3
20	Use of next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in diverse solid tumor types: The Foundation Medicine (FMI) experience with 2,200+ clinical samples. Journal of Clinical Oncology ·Vincent A. Miller,Jeffrey S. Ross,Kai Wang,Siraj M. Ali,Geoff Otto,John A. Curran,Norma Alonzo Palma,Roman Yelensky,Sean R. Downing,Phil Stephens,Doron Lipson,Gary A. Palmer	2013	5

About Norma Alonzo Palma

Norma Alonzo Palma is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 28 papers that have together received 746 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Mechanisms and Therapy (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (325 citations), Cancer Research (164 citations) and Urology (64 citations). Norma Alonzo Palma has collaborated with scholars based in United States, Sweden and Israel. Frequent co-authors include Vincent A. Miller, Siraj M. Ali, Jeffrey S. Ross, Kai Wang, Philip J. Stephens, Doron Lipson, Roman Yelensky, Juliann Chmielecki, Deborah Morosini and Gary A. Palmer. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact